Palisade Bio (PALI) Amortization of Deferred Charges (2015 - 2017)

Palisade Bio (PALI) has 3 years of Amortization of Deferred Charges data on file, last reported at $12127.0 in Q2 2017.

• On a quarterly basis, Amortization of Deferred Charges fell 15.57% year-over-year to $12127.0 in Q2 2017; TTM through Dec 2017 was $59781.0, a 82.8% decrease from a year earlier, with the FY2017 full-year figure at $59781.0, down 82.8% from the prior year.
• Amortization of Deferred Charges for Q2 2017 stood at $12127.0, down from $47654.0 in the prior quarter.
• Over the last five years, Amortization of Deferred Charges for PALI reached as high as $221494.0 in Q3 2015 and fell as low as $12127.0 in Q2 2017.
• Historically, Amortization of Deferred Charges has averaged $105525.8 across 3 years, with a median of $71833.0 in 2016.
• On a YoY basis, Amortization of Deferred Charges climbed as much as 15.57% in 2017 and fell as far as 74.85% in 2017.
• Year by year, Amortization of Deferred Charges stood at $215440.0 in 2015, then tumbled by 70.29% to $63998.0 in 2016, then slumped by 81.05% to $12127.0 in 2017.
• Per Business Quant data, the three most recent Amortization of Deferred Charges figures were $12127.0 in Q2 2017, $47654.0 in Q1 2017, and $63998.0 in Q4 2016.